David Crook

7.5k total citations
147 papers, 5.7k citations indexed

About

David Crook is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, David Crook has authored 147 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Endocrinology, Diabetes and Metabolism, 32 papers in Genetics and 28 papers in Surgery. Recurrent topics in David Crook's work include Hormonal and reproductive studies (32 papers), Estrogen and related hormone effects (31 papers) and Menopause: Health Impacts and Treatments (29 papers). David Crook is often cited by papers focused on Hormonal and reproductive studies (32 papers), Estrogen and related hormone effects (31 papers) and Menopause: Health Impacts and Treatments (29 papers). David Crook collaborates with scholars based in United Kingdom, United States and Switzerland. David Crook's co-authors include Ian F. Godsland, John C. Stevenson, V. Wynn, N.E. Miller, Malcolm Whitehead, Carl V. Felton, Belinda Lees, K.F. Gangar, Anthony J. Proudler and A. La Ville and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

David Crook

143 papers receiving 5.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Crook United Kingdom 40 2.8k 1.5k 1.1k 907 840 147 5.7k
Olavi Ylikorkala Finland 44 1.6k 0.6× 1.5k 1.0× 373 0.4× 1.0k 1.1× 614 0.7× 202 6.1k
Brian W. Walsh United States 29 2.5k 0.9× 2.2k 1.4× 632 0.6× 621 0.7× 818 1.0× 71 5.1k
V. Wynn United Kingdom 44 3.2k 1.2× 973 0.7× 976 0.9× 1.2k 1.4× 722 0.9× 159 6.4k
Ian F. Godsland United Kingdom 52 4.3k 1.5× 1.9k 1.2× 1.5k 1.4× 1.2k 1.4× 2.0k 2.4× 176 9.3k
Eric S. Kilpatrick United Kingdom 37 2.8k 1.0× 848 0.6× 727 0.7× 526 0.6× 652 0.8× 109 4.6k
Giuseppe Bellastella Italy 48 4.3k 1.5× 723 0.5× 1.2k 1.1× 797 0.9× 373 0.4× 208 7.2k
Panagiotis Anagnostis Greece 47 2.4k 0.8× 580 0.4× 1.6k 1.5× 792 0.9× 672 0.8× 211 6.8k
Basil M. Rifkind United States 34 3.3k 1.2× 1.1k 0.7× 2.7k 2.5× 1.2k 1.3× 1.5k 1.8× 109 7.0k
S Edwin Fineberg United States 33 2.4k 0.9× 977 0.7× 593 0.6× 318 0.4× 507 0.6× 83 4.5k
Ramzi Ajjan United Kingdom 49 3.4k 1.2× 1.4k 0.9× 1.6k 1.5× 349 0.4× 1.4k 1.7× 232 7.4k

Countries citing papers authored by David Crook

Since Specialization
Citations

This map shows the geographic impact of David Crook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Crook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Crook more than expected).

Fields of papers citing papers by David Crook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Crook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Crook. The network helps show where David Crook may publish in the future.

Co-authorship network of co-authors of David Crook

This figure shows the co-authorship network connecting the top 25 collaborators of David Crook. A scholar is included among the top collaborators of David Crook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Crook. David Crook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Crook, David, et al.. (2016). Comparison of resistive heating and forced-air warming to prevent inadvertent perioperative hypothermia. British Journal of Anaesthesia. 116(2). 249–254. 58 indexed citations
4.
Anagnostis, Panagiotis, John C. Stevenson, David Crook, Desmond G. Johnston, & Ian F. Godsland. (2016). Effects of gender, age and menopausal status on serum apolipoprotein concentrations. Clinical Endocrinology. 85(5). 733–740. 39 indexed citations
5.
Lattmann, Thomas, et al.. (2008). Kombinierte dorsale und palmare Plattenosteosynthese bei distalen intraartikulären Radiusfrakturen. Der Unfallchirurg. 111(8). 607–612. 6 indexed citations
6.
Crook, David. (2001). Lipid predictors of coronary heart disease and tibolone users. European Heart Journal Supplements. 3(suppl_M). M22–M26. 1 indexed citations
7.
Crook, David, Arnold von Eckardstein, Hans Dieplinger, et al.. (2000). Tibolone lowers plasma high density lipoprotein (HDL) concentrations but does not impair cholesterol efflux from cells. The Journal of the British Menopause Society. 6(2_suppl). 23–23. 1 indexed citations
8.
9.
Crook, David. (1999). Tibolone and the Risk of Arterial Disease. The Journal of the British Menopause Society. 5(1_suppl). 30–33. 2 indexed citations
10.
Crook, David. (1999). Will the Route of Administration Influence the Potential Cardiovascular Benefits of Postmenopausal HRT?. The Journal of the British Menopause Society. 5(1). 35–39.
11.
Crook, David, et al.. (1999). A randomised comparison of the effects of oral versus transdermal 17β‐oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels. BJOG An International Journal of Obstetrics & Gynaecology. 106(9). 948–953. 24 indexed citations
12.
Crook, David & Ian F. Godsland. (1998). Safety Evaluation of Modern Oral Contraceptives. Contraception. 57(3). 189–201. 47 indexed citations
13.
Crook, David. (1997). The metabolic consequences of treating postmenopausal women with non‐oral hormone replacement therapy. BJOG An International Journal of Obstetrics & Gynaecology. 104(s16). 4–13. 42 indexed citations
14.
Edmonds, D. Keith, et al.. (1995). Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial. Fertility and Sterility. 64(3). 474–481. 54 indexed citations
15.
Godsland, Ian F., et al.. (1994). Insuline resistance, lipoproteins, body fat and hemostasis in nonobese men with angina and a normal or abnormal coronary angiogram. Journal of the American College of Cardiology. 23(2). 377–383. 33 indexed citations
16.
Crook, David, et al.. (1994). Dietary polyunsaturated fatty acids and composition of human aortic plaques. The Lancet. 344(8931). 1195–1196. 45 indexed citations
17.
Worthington, M., L. M. Irvine, David Crook, et al.. (1993). A randomized comparative study of the metabolic effects of two regimens of gestrinone in the treatment of endometriosis. Fertility and Sterility. 59(3). 522–526. 16 indexed citations
18.
Godsland, IF, David Crook, M. Worthington, et al.. (1993). Effects of a low-estrogen, desogestrel-containing oral contraceptive on lipid and carbohydrate metabolism. Contraception. 48(3). 217–227. 18 indexed citations
19.
Wynn, V., et al.. (1986). High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men. BMJ. 292(6526). 1013.1–1013. 7 indexed citations
20.
Wynn, V., et al.. (1986). High density lipoprotein is not a major risk factor for ischaemic heart disease in British men. BMJ. 292(6529). 1200.1–1200. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olavi Ylikorkala Breakdown of academic impact, for papers by Brian W. Walsh Breakdown of academic impact, for papers by V. Wynn Breakdown of academic impact, for papers by Ian F. Godsland Breakdown of academic impact, for papers by Eric S. Kilpatrick Breakdown of academic impact, for papers by Giuseppe Bellastella Breakdown of academic impact, for papers by Panagiotis Anagnostis Breakdown of academic impact, for papers by Basil M. Rifkind Breakdown of academic impact, for papers by S Edwin Fineberg Breakdown of academic impact, for papers by Ramzi Ajjan
Rankless by CCL
2026